October 01, 2015 @ 12:11pm PDT
Most by: GeneH (3 predictions)
Click on possible answers in the right column to hide/show them on the graph. You can also hover over any line to see current value at that time. Graphs will begin to show data one hour after the question has been open. The Historical Trend chart does not display all prices ever reached since it is only updated at discrete time intervals, (hourly/daily/weekly, depending on the date range).
Amgen pharmaceuticals has been in the process of testing T-Vec, is a drug specifically aimed at fighting advanced stage melanoma, for the past several years. T-Vec recently underwent an FDA panal and was recommended by a 22-1 vote. This recommendation basically states that the benefits of the drug outweigh the risks. The final vote by the FDA is scheduled for sometime in late October. If approved, the drug would become available to patients with late stage melanoma.
For More Information:
Resolution criteria is according to Amgen pharmaceuticals press releases. http://www.amgen.com This market will be resolved if the answer is known before its end date.